Fig. 1: Kaplan–Meier survival curves for the 23-gene adjusted prognostic gene predictor in 401 patients with advanced stage cHL treated within clinical trials HD12 and HD15. | Leukemia

Fig. 1: Kaplan–Meier survival curves for the 23-gene adjusted prognostic gene predictor in 401 patients with advanced stage cHL treated within clinical trials HD12 and HD15.

From: Gene expression-based outcome prediction in advanced stage classical Hodgkin lymphoma treated with BEACOPP

Fig. 1

A PFS comparing 23-gene adjusted prognostic gene predictor positive (red) and negative (blue) cohorts. B OS comparing 23-gene adjusted prognostic gene predictor positive (red) and negative (blue) cohorts. C OS comparing 23-gene adjusted prognostic gene predictor high-risk (red: age < 45; green: age ≥ 45) and low-risk (blue: age < 45; purple: age ≥ 45) cohorts. D OS comparing 23-gene adjusted prognostic gene predictor high-risk (red: female sex; green: male sex) and negative (blue: female sex; purple: male sex) cohorts.

Back to article page